anemia glutathione metabolism production and turnover in RBC. Schematically presented are Rasburicase-Induced Hemolytic Anemia Secondary to – The Key Role of GSH

Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each Subcutaneous doses are much smaller than oral doses because of injection volume limits and because direct subQ absorption skips the gut

Part II: dysregulated inflammation drives immunopathology

Het wordt door ons lichaam zelf aangemaakt, maar wanneer de productie niet voldoende is, neemt de kans op diverse lichamelijke klachten toe

Overdosing GLP-1 agonists like semaglutide can cause a lot of GI issues, which are severe and prolonged